Literature DB >> 23706758

Individualising treatment for older people with diabetes.

John E Morley1, Alan Sinclair2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706758     DOI: 10.1016/S0140-6736(13)61055-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Authors:  Gerald H Tomkin
Journal:  World J Diabetes       Date:  2014-10-15

2.  Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control study.

Authors:  M Rigato; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2015-09-02       Impact factor: 4.256

Review 3.  What works for whom in the management of diabetes in people living with dementia: a realist review.

Authors:  Frances Bunn; Claire Goodman; Peter Reece Jones; Bridget Russell; Daksha Trivedi; Alan Sinclair; Antony Bayer; Greta Rait; Jo Rycroft-Malone; Christopher Burton
Journal:  BMC Med       Date:  2017-07-28       Impact factor: 8.775

4.  Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis.

Authors:  Alan J Sinclair; Bruce Bode; Stewart Harris; Ujjwala Vijapurkar; Wayne Shaw; Mehul Desai; Gary Meininger
Journal:  J Am Geriatr Soc       Date:  2016-03       Impact factor: 5.562

5.  Managing diabetes in people with dementia: protocol for a realist review.

Authors:  Frances Bunn; Claire Goodman; Jo Rycroft Malone; Peter Reece Jones; Chris Burton; Greta Rait; Daksha Trivedi; Antony Bayer; Alan Sinclair
Journal:  Syst Rev       Date:  2016-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.